CrestOptics

CrestOptics was created in 2011 by Vincenzo Ricco, Andrea Latini, Franco Fazioli and Franco Castelmani with the vision of creating accessible high end solutions for the life science industry based on spinning disk confocal technology. The founders rapidly created a team of physicists, biologists, engineers, designers and highly specialized technicians coming from both the research and the industrial world, establishing the know-how required to build those high end confocal systems that are now essential in the research community for advanced biological discoveries. CrestOptics’ products are supported globally by an experienced network of distributors and integrated as OEM components in prestigious and highly complex equipment.

Since inception CrestOptics has had significant involvement from public and private investment funds which has supported rapid business expansion. In November 2021 Apposite Capital, a specialist international healthcare and life science investor, acquired a majority share holding in CrestOptics in order to partner with the management team and CrestOptics employees to accelerate market penetration globally and launch new products. 

In 2014 CrestOptics established the Joint Lab in collaboration with the Italian Institute of Technology (IIT) to develop new diagnostic solutions for a variety of applications. This collaboration is a further demonstration of CrestOptics’ technological and scientific expertise and in October 2021 this venture was spun off into a newly created sister company, D-TAILS, to continue the development of such products in a focused way.